You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Benserazide

Showing 1 - 25 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)

Enrolling by invitation
  • Parkinson Disease
  • Treatment Adherence
  • Ankara, Turkey
    Ankara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023

Parkinson Disease Trial in Seoul (Levodopa dispersible, Levodopa)

Completed
  • Parkinson Disease
  • Seoul, Korea, Republic of
  • +1 more
May 4, 2021

Parkinson Disease Trial in Warsaw (Fecal Microbiota Transfer)

Enrolling by invitation
  • Parkinson Disease
  • Fecal Microbiota Transfer
  • Warsaw, Poland
    Department of Neurology, Faculty of health sciences, Medical Uni
Jan 10, 2022

Healthy Trial (single-dose madopar, single-dose propranolol, and single-dose by order, single-dose madopar, single-dose , and

Not yet recruiting
  • Healthy
  • single-dose madopar, single-dose propranolol, and single-dose placebo by order
  • +5 more
  • (no location specified)
Sep 13, 2023

Neurosciences Trial (Précurseur de la dopamine, antagoniste D2, PLACEBO)

Not yet recruiting
  • Neurosciences
  • Précurseur de la dopamine
  • +2 more
  • (no location specified)
Feb 1, 2023

Parkinson Disease Trial (Opicapone, L-DOPA/DDCI)

Not yet recruiting
  • Parkinson Disease
  • (no location specified)
Oct 13, 2021

Parkinson Disease Trial in Anyang-si (Ongentys 50mg, Madopar Tab. 125 or Perkin Tab. 25-100mg)

Recruiting
  • Parkinson Disease
  • Ongentys 50mg
  • Madopar Tab. 125 or Perkin Tab. 25-100mg
  • Anyang-si, Gyeonggi-do, Korea, Republic of
    Hallym University Sacred Heart Hospital
Jun 17, 2021

Parkinson Disease, Memory Impairment Trial in Beijing (Madopar monotherapy, senfrol monotherapy, monotherapy)

Recruiting
  • Parkinson Disease
  • Memory Impairment
  • Madopar monotherapy
  • +2 more
  • Beijing, China
    Peking University Third Hospital
Jul 8, 2021

Parkinson Disease, Parkinsonian Disorders, Basal Ganglia Diseases Trial in Beijing, Jinan, Shanghai (Live Combined

Recruiting
  • Parkinson Disease
  • +7 more
  • Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules
  • Placebo
  • Beijing, Beijing, China
  • +9 more
Sep 7, 2021

Parkinson Trial in Dupnitsa (Opicapone 50 mg, Placebo)

Recruiting
  • Parkinson
  • Opicapone 50 mg
  • Placebo
  • Dupnitsa, Bulgaria
    Medical Centre "Asklepii", OOD
Jul 20, 2021

Parkinson's Disease Trial in Australia (Placebo, L-dopa 35 mg, L-dopa 70mg)

Completed
Has Results
  • Parkinson's Disease
  • Placebo
  • +4 more
  • Sydney, New South Wales, Australia
  • +4 more
Jul 27, 2020

Idiopathic Parkinson's Disease Trial in Worldwide (Istradefylline 40 mg, Istradefylline 20 mg, Placebo)

Completed
Has Results
  • Idiopathic Parkinson's Disease
  • Istradefylline 40 mg
  • +2 more
  • Phoenix, Arizona
  • +88 more
Oct 28, 2020

Parkinson's Disease Trial in Portland (carbidopa)

Completed
Has Results
  • Parkinson's Disease
  • Portland, Oregon
    Oregon Health & Science University
Dec 20, 2019

Healthy, Schizotypal Personality Trial in Zürich (200 mg levodopa/50 mg benserazide, Dextrose)

Completed
  • Healthy
  • Schizotypal Personality
  • Zürich, Switzerland
    Collegium Helveticum, ETH & Universität Zürich
Nov 2, 2017

Oxytocin Group, L-DOPA Group, Placebo Group Trial in Beijing (Oxytocin, L-DOPA, Placebos)

Completed
  • Oxytocin Group
  • +2 more
  • Beijing, Beijing, China
    Beijing Normal University
Mar 24, 2019

Parkinson Disease Trial in S. Mamede do Coronado (Placebo, BIA 6-512, Madopar® 250)

Completed
  • Parkinson Disease
  • Placebo
  • +3 more
  • S. Mamede do Coronado, Portugal
    Human Pharmacology Unit (UFH) - BIAL - Portela & Cª, SA
Mar 27, 2017

Idiopathic Parkinson's Disease Trial in Worldwide (Istradefylline 20 mg or 40 mg)

Completed
Has Results
  • Idiopathic Parkinson's Disease
  • Istradefylline 20 mg or 40 mg
  • Phoenix, Arizona
  • +54 more
Jan 9, 2020

Parkinson Disease Trial (Comtan®, Nebicapone, Levodopa/DDCI)

Completed
  • Parkinson Disease
  • (no location specified)
Mar 31, 2017

Parkinson Disease Trial in S. Mamede do Coronado (Placebo, BIA 6-512, Madopar® 250)

Completed
  • Parkinson Disease
  • Placebo
  • +3 more
  • S. Mamede do Coronado, Portugal
    Human Pharmacology Unit (UFH) - BIAL - Portela & Cª, SA
Mar 29, 2017

Parkinson Disease Trial in S. Mamede do Coronado (Madopar® HBS 125, Placebo, BIA 6-512 25 mg dose)

Completed
  • Parkinson Disease
  • Madopar® HBS 125
  • +5 more
  • S. Mamede do Coronado, Portugal
    Human Pharmacology Unit (UFH)
Mar 21, 2017

Metastatic Cancer Trial in Hangzhou (Non Chemotherapy, Chemotherapy and target therapy, Chinese herb medicine)

Unknown status
  • Metastatic Cancer
  • Non Chemotherapy
  • +2 more
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, affiliated with Zhejiang University S
Feb 12, 2019

Parkinson's Disease (PD) Trial in S. Mamede do Coronado (BIA 3-202, Placebo, levodopa 100 mg / benserazide 25 mg)

Completed
  • Parkinson's Disease (PD)
  • BIA 3-202
  • +2 more
  • S. Mamede do Coronado, Portugal
    Human Pharmacology Unit
Jun 13, 2016

Parkinson's Disease Trial in Santa Cruz de la Sierra (MP-Equivalent, MP-Low, MP+DDCI)

Completed
  • Parkinson's Disease
  • MP-Equivalent
  • +5 more
  • Santa Cruz de la Sierra, Bolivia
    Clinica Niño Jesus
Oct 4, 2016

Parkinson Disease Trial in Rome (Levodopa Benserazide Madopar, Levodopa Benserazide Teva Italia)

Completed
  • Parkinson Disease
  • Levodopa Benserazide Madopar
  • Levodopa Benserazide Teva Italia
  • Rome, Italy
    Irccs San Raffaele Pisana
Apr 14, 2016

Parkinson's Disease Trial in S. Mamede do Coronado (BIA 3-202, Placebo, Madopar® 125)

Completed
  • Parkinson's Disease
  • BIA 3-202
  • +2 more
  • S. Mamede do Coronado, Portugal
    Human Pharmacology Unit - BIAL - Portela & Ca, S.A.
May 4, 2016